BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15315866)

  • 1. Managing obesity and glycemic control in insulin-using patients: clinical relevance and practice recommendations.
    Gottesman I
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S17-22. PubMed ID: 15315866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
    Caballero AE
    J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight gain during insulin therapy in patients with type 2 diabetes mellitus.
    Heller S
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S23-7. PubMed ID: 15315867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of type 2 diabetes: oral agents, insulin, and injectables.
    Fonseca VA; Kulkarni KD
    J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S29-33. PubMed ID: 18358251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologic insulin replacement in type 2 diabetes: optimizing postprandial glucose control.
    Robertson C
    Diabetes Educ; 2006; 32(3):423-32. PubMed ID: 16772658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and type 2 diabetes: can we stop the weight gain with diabetes?
    Joffe D; Yanagisawa RT
    Med Clin North Am; 2007 Nov; 91(6):1107-23, ix. PubMed ID: 17964912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin treatment and the problem of weight gain in type 2 diabetes.
    Carver C
    Diabetes Educ; 2006; 32(6):910-7. PubMed ID: 17102158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
    Spellman CW
    J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB; Fonseca VA; Truitt KE; Jones MR
    Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The elderly and diabetes: an age trend and an epidemic converging.
    Marquess JG
    Consult Pharm; 2008 Apr; 23 Suppl B():5-11. PubMed ID: 18540787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stepwise approach to the management of type 2 diabetes.
    Warren RE
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S3-8. PubMed ID: 15315864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of pharmacologic agents for type 2 diabetes mellitus on body weight.
    Pi-Sunyer FX
    Postgrad Med; 2008 Jul; 120(2):5-17. PubMed ID: 18654064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognizing the rising impact of diabetes in seniors and implications for its management.
    Drab SR
    Consult Pharm; 2009 Jun; 24 Suppl B():5-10. PubMed ID: 19555130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of children and adolescents with diabetes mellitus: personal experience].
    Dorchy H
    Rev Med Brux; 2005 Sep; 26(4):S246-54. PubMed ID: 16240870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitioning pharmacologic therapy from oral agents to insulin for type 2 diabetes.
    Tanenberg RJ
    Curr Med Res Opin; 2004 Apr; 20(4):541-53. PubMed ID: 15119992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiazolidinediones-benefits on microvascular complications of type 2 diabetes.
    Viberti G
    J Diabetes Complications; 2005; 19(3):168-77. PubMed ID: 15866064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise training improves glycemic control in long-standing insulin-treated type 2 diabetic patients.
    De Feyter HM; Praet SF; van den Broek NM; Kuipers H; Stehouwer CD; Nicolay K; Prompers JJ; van Loon LJ
    Diabetes Care; 2007 Oct; 30(10):2511-3. PubMed ID: 17626892
    [No Abstract]   [Full Text] [Related]  

  • 18. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
    J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine-tuning therapy with basal insulin for optimal glycemic control in type 2 diabetes: a review.
    Dailey G
    Curr Med Res Opin; 2004 Dec; 20(12):2007-14. PubMed ID: 15701217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of insulin and weight gain: optimizing diabetes nutrition therapy.
    Daly A
    J Am Diet Assoc; 2007 Aug; 107(8):1386-93. PubMed ID: 17659906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.